https://www.selleckchem.com/pr....oducts/caspofungin-a
gate synthesized using PODS exhibited ∼40% lower radioactivity in the kidneys compared to mice administered its maleimide-based counterpart. Taken together, these results demonstrate the improved in vivo performance of the PODS-based radioimmunoconjugate and suggest that a stable, well-defined DAR2 radiopharmaceutical may be suitable for the clinical immunoPET of DLL3-expressing cancers. Several cases of unusual thrombotic events and thrombocytopenia have developed after vaccination with the recombinant adenoviral vector enc
Like
Comment
Share
